Skip to content

Verily Health

Unified patient data for clinical care and research

Raised to date

$300M

of $300M offered across 1 Form D filing

Investors
8
Last filed
Apr 9, 2026

About

Verily Health is a precision health company that turns multimodal patient data into AI-driven insights for clinical care and research. Spun out of Alphabet in March 2026 with a $300 million round led by Series X Capital, it converted from an LLC to a corporation and now operates independently from a Dallas, Texas headquarters, with Alphabet remaining a minority investor. Its platform unifies fragmented health data across health systems and powers a product line spanning clinical research, population health monitoring, chronic care management and a consumer health app. Customers include health systems, life sciences organizations and research institutions; UCHealth and the University of Colorado Anschutz participated in the funding round.

An AI-native platform that unifies fragmented, multimodal patient data across health systems into a single research- and care-grade layer, backed by more than a decade of Alphabet-scale investment in clinical, regulatory and data infrastructure.

Funding

  • EquityFiled Apr 9, 2026Form D
    $300M/ $300M

Product

Verily Pre

Precision health data and AI platform

An AI-native precision health platform that unifies fragmented patient data across health systems into a structured foundation for clinical and research applications.

  • Unification of multimodal patient data across fragmented health system sources
  • AI-native architecture built for precision health applications
  • Shared data foundation across clinical care and research workflows

Built for

Health systems, life sciences and pharmaceutical organizations, and academic research institutions

People on file